Linnea SA Receives Swiss Narcotics License allowing for the Production and Exportation of High THC Active Pharmaceutical Ingredients
January 16, 2023 05:00 ET
|
Linnea
RIAZZINO, Switzerland, Jan. 16, 2023 (GLOBE NEWSWIRE) -- Linnea SA (“Linnea,” or “the Company”), a leading pharmaceutical manufacturer with over 40 years of experience, has been granted a narcotics...
CIPN Market: 5.4% CAGR for Chemotherapy-Induced Peripheral Neuropathy Market Worth $1.17 Billion, Globally, by 2028: The Insight Partners
May 26, 2022 15:07 ET
|
The Insight Partners
New York, May 27, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Chemotherapy-Induced Peripheral Neuropathy Market Forecast to 2028 - COVID-19 Impact and Global...
Narcotics Scanner Market to Garner $12.59 Billion by 2030: Allied Market Research
November 02, 2021 04:49 ET
|
Allied Market Research
Portland, OR, Nov. 02, 2021 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global narcotics scanner market generated $6.89 billion in 2020, and is expected to...
New Report Looks at Trends in Opioid Use and Availability Among Students
April 17, 2019 09:24 ET
|
American Institutes for Research
Washington, D.C., April 17, 2019 (GLOBE NEWSWIRE) -- As efforts to contain the national opioid crisis continue, a new report shows that use of heroin and other types of opioids has fallen among...
Erickson Selected as an Awardee for Counter Narcotics & Global Threats Operations Contracts
March 18, 2016 09:00 ET
|
Erickson, Incorporated
PORTLAND, Ore., March 18, 2016 (GLOBE NEWSWIRE) -- Erickson Incorporated (NASDAQ:EAC), a leading global provider of aviation services, has been selected as a subcontractor by a pool of prime...
Elite Pharmaceuticals Initiates Pivotal Bioequivalence Study for Second Opioid Abuse Deterrent Product
January 14, 2014 13:21 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Jan. 14, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") ("Elite") (OTCBB:ELTP) announced today the first dosing of a pivotal bioequivalence study in...